Impact Biomedical (IBO) Times Interest Earned (2022 - 2026)
Impact Biomedical's (IBO) quarterly Times Interest Earned came in at -$0.21 in Q1 2026, up 73.67% YoY from -$0.12 in Q1 2025, and up 75.28% on a QoQ basis from -$0.84 in Q3 2025.
Impact Biomedical (IBO) Times Interest Earned (2022 - 2026) Analysis & Trends
Impact Biomedical (IBO) has 5 years of Times Interest Earned data on file, last reported at -$0.21 in Q1 2026.
- Quarterly Times Interest Earned rose 73.67% year-over-year to -$0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.49 (up 97.84% YoY) and the FY2024 annual result came in at -$25.83, down 8465.94% from the prior year.
- Times Interest Earned climbed to -$0.21 in Q1 2026, from -$0.84 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.21 in Q1 2026 to a low of -$97.15 in Q4 2024.
- A 5-year average of -$9.77 and a median of -$0.97 in 2023 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 91.29% in 2024, down 966.2% in 2024.
- Tracing IBO's Times Interest Earned over 5 years: stood at -$10.42 in 2022, then climbed by 12.59% to -$9.11 in 2023, then plunged by 966.2% to -$97.15 in 2024, then soared by 99.14% to -$0.84 in 2025, then surged by 75.28% to -$0.21 in 2026.
- The last three Times Interest Earned figures came in at -$0.21 (Q1 2026), -$0.84 (Q3 2025), and -$0.9 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 | -10.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06 |
| Mar 31, 2026 | -0.21 |
| Sep 30, 2025 | -0.84 |
| Jun 30, 2025 | -0.90 |
| Mar 31, 2025 | -0.79 |
| Dec 31, 2024 | -97.15 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -0.56 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -9.11 |
| Sep 30, 2023 | -0.97 |
| Jun 30, 2023 | -0.91 |
| Mar 31, 2023 | -7.95 |
| Dec 31, 2022 | -10.42 |
| Sep 30, 2022 | -9.66 |
| Jun 30, 2022 | -5.40 |